- Memorandum and Articles of Association Signed by the Sponsors: December 19, 1983;
|
- Certificate of Incorporation as Private Ltd. Company: December 22, 1983;
|
- Commercial Production Started: May 1986;
|
- Converted into a Publicly Listed Company (PLC): 1989;
|
- Subscription Opened on Initial Public Offerings (IPO): July 15, 1989;
|
- Subscription Closed: September 14, 1989;
|
- Listed in DSE: July 1990;
|
- Started of Ophthalmic products: 1995;
|
- Listed in CSE: December 24, 1996;
|
- Company Crossed the Number of Products to 100: December 2003;
|
- Natural Medicine Unit Started Production and Marketing: 2008;
|
- First Dividend Declared (After IPO): March 31, 1993 in the 7th AGM;
|
- First ISO-9001 Certification (ISO): August 18, 2004;
|
- Started Production of Marketing of Injectable Products: December 2004;
|
- Obtained Certification of Membership from BAPLC: November 30, 2005;
|
- Registered as Depository Participant of CDBL: January 03, 2009;
|
- Dematerialized Securities Trading Started on: January 04, 2009;
|
- Commercial Production in the state-of-art Cephalosporin Plant: 2016;
|
- OSD Production in Distinct Compliant Plant: 2019.
|
